01-25-2019, 10:23 AM
(01-25-2019, 09:26 AM)stockguru Wrote: ABBV has become a real dud. Down $4 pre-market. One of those stocks that just can’t seem to get things right even with all dividend increases.ABBV is regarded by many as a one drug pony as the patent expiration approaches. That may be true to some extent, for now. It's a solid company that will reward you over time. All pharma companies go through phases like this. I started a one stock Roth IRA for my wife about 1998. My wife is a nurse and selected PFE. It's an extreme example as the recovery took forever, but bailing in frustration before it finally ran wouldn't have been a good idea either. I did that stupid trick with MSFT.
Hope this was encouraging because that was my intent.